Presentation brochure Main challenges in p
ultry farMing
Vaccinati n failures Mohamed Faizal Abdul-Careem
main challenges in poultry farming
Vaccination failures
Main challenges in p
ultry farMing
Vaccinati n failures Mohamed Faizal Abdul-Careem
Author: Mohamed Faizal Abdul-Careem. Format: 17 x 11 cm. Number of pages: 80. Number of images: 43. Binding: paperback, wire-o.
RETAIL PRICE
35 â‚Ź
A vaccination failure occurs when the chickens do not develop suitable antibody titer levels and/or are susceptible to a field disease outbreak. Therefore, an updated review (visual-type) has been thoroughly developed in order to highlight the importance of detecting and solving the major vaccination failures in commercial chickens to control diseases affecting this species. The handbook has been written by a prestigious expert with a wide experience in this field. Numerous graphic resources have been included to complement the information provided and make the contents more understandable and accessible to readers.
Vilmos Varga/shutterstock.com
Vaccination failures
Presentation of the book First ever poultry vaccine was introduced during late 1800 and currently poultry vaccines are widely used in the control of economically important poultry diseases. The aim of the use of vaccines in poultry farming is to reduce the clinical and production impacts of the infections rather than the prevention of various infections. This approach has lead to limitations in poultry viral diseases control using vaccination such as vaccination failures. The causes of vaccine failures may include: (a) emergence of variants or heterogonous strains of pathogens, (b) spread of viral strains used for vaccination among individual birds within the flock and change in virulence level during the bird to bird passage, (c) increased virulence of attenuated vaccine strains linked to reactivation of vaccine virus from latency, and (d) increased virulence of the field viral strains. Understanding the factors that have lead to vaccine failures and ways of overcoming these limitations are vital to preserve the efficacy of currently used vaccines until novel vaccines or alternative measures for poultry disease control are developed. The objective of this book is to provide an overview of vaccine failures currently experienced in poultry farming globally including causes and scientific reasons, examples and suggested ways of overcoming the issue. Mohamed Faizal Abdul-Careem
Vaccination failures
The author Mohamed Faizal Abdul-Careem
He has expertise and strong interests in the area of avian viral immunology. He has around 37 manuscripts published in peer-reviewed journals and 90 % of these manuscripts are on avian viral immunology. His research programme at the University of Calgary is supported by grants from Canadian federal, provincial and poultry industry sources such as Natural Sciences and Engineering Research Council of Canada, Alberta Livestock and Meat Agency (ALMA), and Canadian Poultry Research Council. He has established stateof-the-art research facility for his experimental animal and laboratory work at the University of Calgary.
hkeita/shutterstock.com
Dr. Mohamed Faizal Abdul-Careem is Associate Professor (virology) at the University of Calgary (Canada) since 2010. He has obtained his basic veterinary degree (BVSc) from the University of Peradeniya (Sri Lanka) and a Master of Veterinary Medicine degree (MVM) from the University of Glasgow Veterinary School (UK) in 1995. He completed his PhD degree from the University of Guelph (Canada) in 2008. His doctoral thesis entitled “Characterization of Host Responses Following Marek’s Disease Virus Infection or Vaccination Against Marek’s Disease”. Following his PhD degree, he was awarded a prestigious Canadian Institutes of Health Research Fellowship to conduct post-doctoral research on innate immune responses generated against mucosal viral infections at the Center for Gene Therapeutics of the McMaster University (Canada). He is diplomate of American College of Poultry Veterinarians (ACPV) and American College of Veterinary Microbiologists (ACVM).
Communication services Website Online visualisation of the sample chapter. Presentation brochure in PDF format. Author´s CV. Sample chapter compatible with iPad.
www.grupoasis.com/promo/vaccination_failures
Main challenges in p
ultry farMing
Vaccinati n failures Mohamed Faizal Abdul-Careem
Table of contents 1. Introduction Significance of poultry infectious diseases Control options for poultry infectious diseases General definition of vaccination History of poultry vaccines and vaccination Economic benefits of vaccination
2. Types of poultry vaccines Killed vaccines Live attenuated vaccines DNA vaccines Recombinant vaccines
3. Vaccination techniques Spray vaccination Drinking water vaccination Parenteral routes
In ovo vaccination
4. Vaccine-mediated immune responses Mechanisms of induction of vaccine-mediated immune responses
5. Evaluation of vaccine efficacy Monitoring vaccine take Monitoring antibody response Monitoring protection
6. Causes of vaccination failures General definition of vaccination failure Evolution of pathogens Poor cross protection between serotypes, pathotypes and strains of the same pathogen Maternal antibody interference Early exposure to pathogens Exposure to heavy pathogen loads Immune suppressive conditions of the host Uneven vaccine uptake Improper vaccine storage and handling during vaccination
7. Field examples of vaccination failures Marek’s disease Infectious bronchitis Infectious bursal disease Newcastle disease Infectious laryngotracheitis Avian influenza Fowlpox
8. Overcoming vaccination failures in poultry flocks References
1
Introduction
Vaccination failures
Introduction
First ever poultry vaccine was introduced during late 1800, and currently poultry vaccines are widely used for the control of economically important poultry diseases. Most probably, chickens are the most vaccinated farm animal species today; an average broiler chicken may receive up to eight vaccinations whereas an average commercial layer chicken may receive up to 12 vaccinations during their short production cycles. An average breeder chicken may receive up to 20 vaccinations. The aim of the use of vaccines in poultry farming is to reduce the clinical and production impacts of the infections rather than the prevention of various infections. This approach along with the heavy use of vaccines in poultry farming has lead to limitations in poultry viral disease control using vaccination such as vaccination failures.
01_intro_vaccination.indd 4
4
23/11/15 15:13
IntroductIon
Significance of poultry infectious diseases Currently, an array of vaccines is employed for the control of viral, bacterial and parasitic diseases in chickens. Table 1. Aetiological agents of economically important poultry infectious diseases that are controlled employing various means including vaccination. Viruses
Bacteria
Parasites
Infectious bronchitis virus.
5
Infectious bursal disease virus. Infectious laryngotracheitis virus.
Salmonella species.
Newcastle disease virus.
Escherichia coli.
Chicken anaemia virus.
Clostridium species.
Marek’s disease virus.
Mycoplasma species.
Avian leucosis virus.
Haemophilus paragallinarum.
Avian encephalomyelitis virus.
Bordetella species.
Inclusion body hepatitis virus.
Chlamydia species.
Eimeria species.
Egg drop syndrome virus.
Pasteurella multocida.
Helminths.
Infectious diseases caused by these aetiological agents may represent around 30 % of the issues faced by the poultry industry in the world.
01_intro_vaccination.indd 5
23/11/15 15:13
1
Introduction
Vaccination failures
Control options for poultry infectious diseases Of the measures employed for the control of poultry infectious diseases, vaccination has gained increasing attention when compared to use of antimicrobials and biosecurity measures.
Antimicrobial feed additives
Vaccination
6
Biosecurity measures
Figure 1. Current measures employed for poultry infectious disease control.
01_intro_vaccination.indd 6
23/11/15 15:13
IntroductIon
General definition of vaccination Vaccination involves administration of antigens in terms of whole pathogen or a related organism (attenuated or killed) or parts of the pathogen with a view of eliciting protective adaptive immune responses against the pathogen mimicking the development of naturally acquired immune responses. The goal of this artificial induction of immune responses is to protect the animals against infectious diseases.
Vaccination/antigen administration
Antigen presentation in secondary lymphoid organs
Adaptive immune response development
Protection from exposure
7
Spleen T cells Antigen presenting cells
Antibody response Cluster of differentiation (CD)8+ T cells response Pathogen
Figure 2. Vaccination involves antigen administration leading to antigen presentation and development of protective adaptive immune responses.
01_intro_vaccination.indd 7
23/11/15 15:13
1
Introduction
Vaccination failures
History of poultry vaccines and vaccination In 1879, Louis Pasteur accidentally produced the first ever laboratory-developed vaccine: that happened to be the vaccine for fowl cholera in chickens. This landmark discovery followed the production and licensing of number of poultry vaccines that are summarized in the Figure 3. Fowlpox vaccine development
1879
1918
First infectious laryngotracheitis vaccine licensed in the USA
1933
Louis Pasteur discovered the first ever laboratory-developed vaccine: the vaccine for fowl cholera
Introduction of first Eimeria vaccine for the control of coccidiosis
1946
1950s
First avian encephalomyelitis vaccine licensed in the USA
1953
First Newcastle disease vaccine licensed in the USA
1962
First infectious bursal disease vaccine licensed in the USA
1967
First infectious bronchitis vaccine licensed in the USA
Proposal to use pox virus as a vector for recombinant vaccines
1968
8
1982
Introduction of a vaccine to prevent Marek’s disease in chickens using herpesvirus of turkeys
Figure 3. Important discoveries related to poultry vaccines since first description of the fowl cholera vaccine in late 1800.
01_intro_vaccination.indd 8
23/11/15 15:13
IntroductIon
Economic benefits of vaccination Poultry infectious diseases cause significant economic impacts; in commercial layers, broiler breeders and backyard flocks, losses are due to decrease in egg production, immune suppression, poor weight gains and mortality, whilst in commercial broilers, production losses are due to immune suppression, poor weight gains, carcass condemnation at processing and mortality. Table 2. Losses due to infectious diseases could be reduced by vaccination in chickens. Status of vaccination against infectious diseases
Commercial layers Broiler breeders
9
Commercial broilers
Backyard flocks
Vaccinated chickens
Protection from immune suppression, production losses and mortality.
Protection from immune suppression, bodyweight loss, mortality and carcass condemnation.
Protection from immune suppression, production losses and mortality.
Unvaccinated chickens
Outbreaks with up to 100 % mortality rates, immune suppression and production losses.
Immune suppression, bodyweight loss, mortality and carcass condemnation.
Immune suppression, production losses and mortality.
01_intro_vaccination.indd 9
23/11/15 15:13
2
Types of poultry vaccines
Vaccination failures
Types of poultry vaccines » The aims of poultry vaccines are to improve the health and welfare of poultry species and increase poultry meat and egg production in a cost-effective manner. These aims have led to the development of poultry vaccines from wholepathogen preparations (attenuated or killed) to genetically engineered DNA and recombinant vaccines.
» Additionally, some of the vaccines used for the control of Marek’s disease (MD) in chickens contain herpesvirus of turkeys (HVT) and SB-1 strains of herpesviruses which are non-pathogenic and do not require attenuation in the laboratory. Lentogenic viral strains used against Newcastle disease (ND) and pigeon pox virus used against fowlpox are some other examples of live non-attenuated vaccines used in poultry flocks. Live Eimeria organisms are also used without attenuation for the control of coccidiosis in chickens.
02_types_vaccination.indd 10
10
23/11/15 15:12
Types of poulTry vaccines
The pathogen is attenuated by passage through in vitro culture systems
DNA encoding antigen of a pathogen is inserted into a genome of viral vector
Live attenuated vaccine
Recombinant vaccine
11
Figure 4. Major types of poultry vaccines that are available or currently in development for poultry infectious disease control.
02_types_vaccination.indd 11
Target pathogen
Killed vaccine
DNA vaccine
The pathogen is mainly inactivated by heat or chemical treatments
DNA encoding antigen of a pathogen is inserted into a plasmid vector
23/11/15 15:12
2
Types of poultry vaccines
Vaccination failures
Killed vaccines Most of the poultry killed vaccines are developed against viral diseases. The inactivation of the virus is done via heat or chemical treatments. Although the killed vaccines are stable, the non-infectious nature of the killed vaccines reflects in the quality of the vaccine induced adaptive immune responses. Since they are only able to stimulate antibody-mediated rather than both cell- and antibody-mediated immune responses, the generated immune responses are weak, require multiple vaccine administrations and the vaccine formulations require combining with expensive adjuvant compounds. In general, killed vaccines are used aiming to control clinical signs of a disease rather than infection following vaccination.
02_types_vaccination.indd 12
12
23/11/15 15:12
Types of poulTry vaccines
Antigen presenting cells T cells
Vaccination
No change in antigen amount
Secondary lymphoid organ
Adaptive immune responses
13 Antibody response
4
8
12
16
20
24
28
Days post-vaccination
Figure 5. Non-infectious nature of killed vaccines results antibody-mediated adaptive immune responses rather than CD8+ T cell-mediated immune responses following vaccination.
02_types_vaccination.indd 13
23/11/15 15:12
2
Types of poultry vaccines
Vaccination failures
Live attenuated vaccines There is an array of poultry live attenuated vaccines that are developed against poultry viral diseases. The attenuation of the virus is done via series of cell culture or embryo passages. Passage of the virus may induce random mutations leading to reduced virulence. Since the attenuated viral strains are able to replicate in the host inducing mild infection, it will lead to both cell- and antibody-mediated immune responses without an adjuvant combination. The potential limitations of theses vaccines are residual virulence and reversion of the virulence.
02_types_vaccination.indd 14
14
23/11/15 15:12
Types of poulTry vaccines
Antigen presenting cells T cells
Vaccination
Vaccine strain replication
Secondary lymphoid organ
Adaptive immune responses
15 Antibody response CD8+ T cell response
4
8
12
16
20
24
28
Days post-vaccination
Figure 6. Infectious nature of live attenuated vaccines leads to both antibody- and cell-mediated immune responses following vaccination.
02_types_vaccination.indd 15
23/11/15 15:12
2
Types of poultry vaccines
Vaccination failures
DNA vaccines The DNA encoding an antigen of a pathogen is inserted to vector plasmid and naked DNA with the insert is used for vaccination. Since the antigen of interest is produced within the animal and presented, the vaccination elicits both cell- and antibody-mediated immune responses. It is also possible to insert genes of antigens of multiple pathogens into one plasmid vector and number of vaccinations in poultry could be reduced. Due to the stability of the vaccine in various environmental temperature conditions, this type of vaccines is ideal for resource poor settings. Although experimental data is available to support the success of this technology in chickens, currently no DNA vaccines are available commercially for poultry infectious disease control.
02_types_vaccination.indd 16
16
23/11/15 15:12
Types of poulTry vaccines
Antigen presenting cells T cells
Antigen processing
Transfection of muscle cells
Vaccination
Secondary lymphoid organ
Adaptive immune responses
17 Antibody response
CD8+ T cell response
4
8
12
16
20
24
28
Days post-vaccination
Figure 7. DNA vaccination results in antigen of interest being produced within myocytes and recognized by antigen presenting cells and presented. The DNA vaccination elicits both cell- and antibody-mediated immune responses.
02_types_vaccination.indd 17
23/11/15 15:13
2
Types of poultry vaccines
Vaccination failures
Recombinant vaccines Poxviruses and herpesviruses, as vectors, can accommodate large number of genes of antigens derived from various pathogens and can infect avian cells, resulting in the expression of these encoded proteins. Since the antigen of interest is produced within the animal and presented, the vaccination elicits both cell- and antibody-mediated immune responses. Currently, a number of commercial recombinant poultry viral vaccines is available for infectious disease control in chickens.
02_types_vaccination.indd 18
18
23/11/15 15:13
Types of poulTry vaccines
Antigen presenting cells T cells
Viral vector replication
Vaccination
Target antigen production
Antigen processing
Secondary lymphoid organ
Adaptive immune responses
19 Antibody response
CD8+ T cell response
4
8
12
16
20
24
28
Days post-vaccination
Figure 8. The viral vector carrying gene encoding antigen of pathogen replicates in chicken, expresses the antigen, presented, and both antibody- and cell-mediated immune responses are generated following vaccination with recombinant vaccines.
02_types_vaccination.indd 19
23/11/15 15:13
The publishing strength of Grupo AsĂs Editorial Servet, a division of Grupo AsĂs, has become one of the reference publishing companies in the veterinary sector worldwide. More than 15 years of experience in the publishing of contents about veterinary medicine guarantees the quality of its work. With a wide national and international distribution, the books in its catalogue are present in many different countries and have been translated into nine languages to date: English, French, Portuguese, German, Italian, Turkish, Japanese, Russian and Chinese. Its identifying characteristic is a large multidisciplinary team formed by doctors and graduates in Veterinary Medicine and Fine Arts, and specialised designers with a great knowledge of the sector in which they work. Every book is subject to thorough technical and linguistic reviews and analyses, which allow the creation of works with a unique design and excellent contents. Servet works with the most renowned national and international authors to include the topics most demanded by veterinary surgeons in its catalogue. In addition to its own works, Servet also prepares books for companies and the main multinational companies in the sector are among its clients.
Servet (División de Grupo Asís Biomedia S.L.) Centro Empresarial El Trovador, planta 8, oficina I Plaza Antonio Beltrán Martínez, 1 • 50002 Zaragoza (España) Tel.: +34 976 461 480 • Fax: +34 976 423 000 • www.grupoasis.com